After the modified vector enters a target cell, its RNA genome is reverse-transcribed into DNA. The viral integrase then inserts that DNA into host chromosomes, placing the transgene within the cell’s genomic material. This sequence of molecular events explains why the introduced genetic material can remain associated with the cell and support long-term expression.
Removing pathogenic viral genes changes the vector from a disease-causing virus into a delivery system for genetic material. The resulting construct retains the functions needed to enter cells, generate a DNA copy, and integrate that copy, while excluding the pathogenic genes. This design is central to using lentiviral vectors in genetic engineering research.
A major practical advantage is its ability to transduce both dividing and nondividing cells. Consequently, researchers can apply the method to cell populations that differ in their growth behavior rather than restricting experiments to actively proliferating cultures. This broadens the range of cell-based genetic studies and supports long-term investigations in otherwise difficult-to-modify cell types.
Integration places the added sequence within the host cell’s chromosomes instead of leaving it as a temporary genetic component. As a result, the transgene can be maintained through cellular propagation and support stable inheritance and expression. This persistence is important when experiments require continued observation of gene function rather than a short-lived response after delivery.
The central workflow begins when a modified lentiviral vector enters the target cell. Its RNA genome is then copied into DNA by reverse transcription, and integrase inserts the resulting DNA into host chromosomes. The integrated transgene can subsequently remain associated with the cell during continued study, providing the foundation for stable genetic analysis.
Researchers use this approach to generate transgenic cell lines in which an added sequence can remain present and expressed over extended experiments. Such systems are useful for examining gene function because the introduced transgene is integrated into the genome. The method therefore supports genetic engineering studies that require persistent rather than transient modification of cultured cells.
In genetics, the method supports creation of transgenic model organisms and investigation of disease-associated variants. Researchers can use stable introduction and expression of selected sequences to examine how those sequences relate to gene function or disease biology. These applications connect molecular genome modification with cellular models and organism-level studies of inherited or disease-relevant genetic changes.